Skip to content

PSNL

Personalis, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$17.20
+2.20%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue69.7M69.6M84.6M73.5M65.0M
Cost of Revenue60.8M53.9M57.8M55.3M51.7M
Gross Profit8.8M15.8M26.8M18.2M13.3M
Operating Expenses
R&D Expense56.1M50.3M48.9M64.8M64.9M
SG&A Expense67.0M53.6M46.2M49.7M64.0M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses123.1M103.8M95.1M114.5M128.9M
Cost and Expenses184.0M157.7M152.9M169.8M180.6M
Operating Income (EBIT)(114.3M)(88.1M)(68.3M)(96.3M)(115.5M)
Non-Operating
Interest Income7.4M7.2M5.5M5.9M2.4M
Interest Expense213.0K205.0K24.0K110.0K201.0K
Net Interest Income7.2M7.0M5.5M5.8M2.2M
Other Non-Op Income/Expense7.2M6.8M(13.0M)(11.9M)2.3M
Non-Operating Income (excl Interest)(7.4M)(7.0M)13.0M11.8M(2.5M)
EBT (Pre-Tax Income)(107.1M)(81.2M)(81.3M)(108.2M)(113.3M)
Income Tax Expense33.0K21.0K18.0K83.0K40.0K
Bottom Line
Net Income(107.2M)(81.3M)(81.3M)(108.3M)(113.3M)
Earnings from Cont. Ops(107.2M)(81.3M)(81.3M)(108.3M)(113.3M)
Earnings from Discont. Ops
Bottom Line Net Income(107.2M)(81.3M)(81.3M)(108.3M)(113.3M)
Per Share
Basic EPS($1.09)($0.91)($1.37)($2.25)($2.48)
Diluted EPS($1.09)($0.91)($1.37)($2.25)($2.48)
Revenue Per Share$0.66$0.78$1.43$1.53$1.42
Shares
Basic Shares Outstanding105.4M89.2M59.3M48.2M45.7M
Diluted Shares Outstanding105.4M89.2M59.3M48.2M45.7M
Profitability Metrics
EBITDA(97.2M)(71.0M)(70.3M)(96.8M)(104.6M)
D&A9.7M10.0M10.9M11.3M8.4M
EBIT(106.9M)(81.0M)(81.2M)(108.1M)(113.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026